HomeBAFNAPH • NSE
add
Bafna Pharmaceuticals Ltd
Previous close
₹86.95
Day range
₹83.00 - ₹86.00
Year range
₹73.25 - ₹119.00
Market cap
2.04B INR
Avg Volume
2.84K
P/E ratio
27.65
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 413.98M | -2.00% |
Operating expense | 115.43M | 87.53% |
Net income | 14.55M | -72.91% |
Net profit margin | 3.52 | -72.33% |
Earnings per share | — | — |
EBITDA | 28.65M | -68.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.96M | -82.13% |
Total assets | 1.48B | 13.97% |
Total liabilities | 668.43M | 19.09% |
Total equity | 808.39M | — |
Shares outstanding | 23.47M | — |
Price to book | 2.52 | — |
Return on assets | — | — |
Return on capital | 3.96% | — |
Cash Flow
Net change in cash
(INR) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 14.55M | -72.91% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1981
Website
Employees
588